Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Director/PDMR Shareholding

7 Mar 2025 14:39

RNS Number : 8762Z
IDOX PLC
07 March 2025
 

7 March 2025

Idox plc

('Idox' or the 'Group' or the 'Company')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRS")

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset intensive sectors, announces that, on 7 March 2025 the following PDMRs (the "Grantees") received conditional awards over the number of Ordinary Shares each in the Company ("Ordinary Shares") shown below (the "Awards"), in accordance with the rules of the Long Term Incentive Plan 2023 ("2023 LTIP").

 

 

Standard Award

 

Name of Director/PDMR

Number of Shares Awarded

Type of Award

David Meaden

599,110

Conditional

Anoop Kang

470,729

Conditional

Jonathan Legdon

470,729

Conditional

 

 

The vesting and holding period of each Award is subject to the rules of the 2023 LTIP and the Grantee agreeing to be bound by the terms of their Award.

 

The Awards will normally vest on the third anniversary of the grant date. No consideration is payable by grantees on either the grant or vesting of the Awards.

 

Three independent performance conditions will be used:

 

o Absolute TSR (50% weighting)

 

o Adjusted EPS (25% weighting)

 

o Revenue (25% weighting)

 

 

The performance condition applying to half of the Awards (the "TSR Part") will measure the Company's absolute total shareholder return ("TSR") performance over a three-year period. The measurement period for the Awards shall comprise three consecutive financial years of the Company, starting with the 2025 financial year. No portion of the TSR Part will vest unless the Company's TSR performance achieves a 5% CAGR over the measurement period at which point 18.75% of the TSR Part will vest, rising to a 10% CAGR on a straight-line basis at which point 75% of the TSR Part will vest and thereafter on a straight-line basis to 100% vesting for the Company's TSR performance achieving a 12% CAGR over the measurement period.

 

The performance condition applying to a separate quarter of the Awards (the "EPS Part") will measure the Company's adjusted earnings per share performance over a three-year measurement period starting with the 2025 financial year. No portion of the EPS Part will vest unless the Company's adjusted EPS for the 2027 financial year is 2.94p at which point 18.75% of the EPS Part will vest, rising to 3.27p on a straight-line basis at which point 75% of the EPS Part will vest and thereafter on a straight-line basis to 100% vesting for the Company's EPS for the 2027 financial year being 3.33p.

 

The performance condition applying to a separate quarter of the Awards (the "Revenue Part") will measure the company's revenue performance over a three-year measurement period starting with the 2025 financial year. No portion of the Revenue Part will vest unless the Company's revenue for the 2027 financial year is £104.33m, at which point 18.75% of the Revenue part will vest, rising to £110.35m on a straight-line basis at which point 75% of the Revenue Part will vest and thereafter on a straight-line basis to 100% vesting for the Company's revenue for the 2027 financial year being £113.44m.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

David Meaden

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification /Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

Conditional Award of Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

599,110

d.

Aggregated information· Aggregated volume· Price

Price(s)

Volume(s)

n/a

599,110

e.

Date of the transaction

7 March 2025

f.

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Anoop Kang

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification /Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

Conditional Award of Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

470,729

d.

Aggregated information· Aggregated volume· Price

Price(s)

Volume(s)

n/a

470,729

e.

Date of the transaction

7 March 2025

f.

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Ledgon

2.

Reason for the notification

a.

Position/status

Chief Operating Officer

b.

Initial notification /Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

Conditional Award of Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

470,729

d.

Aggregated information· Aggregated volume· Price

Price(s)

Volume(s)

n/a

470,729

e.

Date of the transaction

7 March 2025

f.

Place of the transaction

Outside a trading venue

 

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

 

For further information please contact:

 

Idox plc

+44 (0) 333 011 1200

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive Officer

 

Anoop Kang, Chief Financial Officer

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Benjamin Cryer

 

Kate Bannatyne

 

Adam Telling

MHP Group

+ 44 (0) 7885 447944

Reg Hoare

 idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

Finn Taylor

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVSVDIDIIE
Date   Source Headline
29th May 20267:00 amRNSCancellation - IDOX Plc
26th May 20261:45 pmRNSRule 19.6(b) update
18th May 202610:22 amRNSHolding(s) in Company
12th May 20268:21 amRNSCompulsory Acquisition of Idox Shares
7th May 20263:52 pmRNSHolding(s) in Company
5th May 20267:00 amRNSAcceptance Level Update
28th Apr 20266:00 pmRNSIDOX
28th Apr 20267:00 amRNSProposed cancellation of Idox shares on AIM
27th Apr 20267:00 amRNSAcceptance Level Update
22nd Apr 20262:26 pmRNSForm 8.3 - Idox plc
22nd Apr 20261:00 pmRNSReplacement: Director/PDMR Shareholding
22nd Apr 202611:24 amRNSDirector/PDMR Shareholding
21st Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
21st Apr 20269:13 amBUSForm 8.3 - [IDOX PLC - 20 04 2026] - (CGWL)
21st Apr 20267:45 amRNSDisclosure Table
21st Apr 20267:00 amRNSOffer Declared Unconditional
20th Apr 20263:46 pmRNSUpdate on Letters of Intent
20th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
20th Apr 20269:12 amBUSForm 8.3 - [IDOX PLC - 17 04 2026] - (CGWL)
20th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20263:26 pmRNSForm 8.3 - IDOX PLC
17th Apr 20263:25 pmRNSForm 8.3 - Idox plc
17th Apr 20262:10 pmRNSHolding(s) in Company
17th Apr 20261:03 pmRNSForm 8.3 - IDOX PLC
17th Apr 202612:43 pmRNSForm 8.3 - Idox plc
17th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
17th Apr 20269:05 amBUSForm 8.3 - [IDOX PLC - 16 04 2026] - (CGWL)
17th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20267:00 amRNSForm 8.3 - Idox plc
16th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:12 pmRNSForm 8.3 - Idox plc
16th Apr 20261:15 pmRNSForm 8.3 - IDOX PLC
16th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
16th Apr 20268:51 amBUSForm 8.3 - [IDOX PLC - 15 04 2026] - (CGWL)
16th Apr 20267:00 amRNSSatisfaction of Regulatory Conditions
15th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
15th Apr 20262:38 pmRNSForm 8.3 - Idox plc
15th Apr 20269:25 amBUSForm 8.3 - [IDOX PLC - 14 04 2026] - (CGWL)
15th Apr 20267:00 amRNSUpdate on Letters of Intent
14th Apr 20264:01 pmRNSForm 8.3 - Idox plc
14th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
14th Apr 20261:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 202612:37 pmRNSForm 8.3 - Idox plc
14th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
14th Apr 202610:04 amBUSForm 8.3 - [IDOX PLC - 13 04 2026] - (CGWL)
14th Apr 20267:00 amRNSUpdate on Letters of Intent
13th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
13th Apr 202610:46 amBUSForm 8.3 - [IDOX PLC - 10 04 2026] - (CGWL)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.